The NAFLD control rats showed a significant (P ≤ 0.05) increase in serum ALT, FFA, and insulin levels along with HOMA index, in consort with a nonsignificant increase in serum glucose, as compared to ND control rats. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.